Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03099681 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Observational Study on Epithelioid Sarcoma

Study acronym: EPISObs
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Nov 1, 2025 to Nov 1, 2028
    • Study completion date: Mar 31, 2028 to Mar 31, 2030
    v12
  2. Study completion date: Dec 1, 2025 to Mar 31, 2028v11
  3. Primary completion date: Dec 1, 2024 to Nov 1, 2025
    • Study completion date: Dec 1, 2024 to Dec 1, 2025
    v10
  4. Primary and study completion dates: Dec 1, 2022 to Dec 1, 2024
    • Study sites: 13 to 11
    v9
  5. Study sites: 15 to 13v8
Show 6 earlier versionsHide 6 earlier versions
  1. Site details revised at 5 of 15 sitesv7
  2. Primary completion date: May 1, 2020 to Dec 1, 2022
    • Study completion date: Dec 1, 2020 to Dec 1, 2022
    v6
  3. Re-verified, no change to tracked fieldsv5
  4. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised at 15 of 15 sites
    v4
  5. Re-verified, no change to tracked fieldsv3
  6. Start date changed from estimate of May 1, 2017 to Aug 22, 2017
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Site details revised at 15 of 15 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Italian Sarcoma Group
11 trials monitored
See 1 trial at risk
Sarcoma
1,026 trials monitored
See 67 trials at risk
Prospective Italian study aimed to provide a description of the population affected by Epithelioid Sarcoma (ES)
Trial Details
NCT Number NCT03099681
Lead Sponsor Italian Sarcoma Group
Conditions
(from sponsor)		 Epithelioid Sarcoma
Related terms Sarcoma
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov